Skip to content

Clinical trials

Pulmonary Emphysema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Emphysema Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20063
20073
20081
20092
20122
20131
20141
20151
20162
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grifols Therapeutics LLC6
Aeris Therapeutics5
AstraZeneca1
Boehringer Ingelheim1
Kamada, Ltd.1
Mayo Clinic1
Mesoblast, Inc.1
National Center for Complementary and Integrative Health (NCCIH)1
Olympus Corporation of the Americas1
Pulmonx Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Emphysema22
Pulmonary Disease, Chronic Obstructive16
Emphysema9
Lung Diseases8
alpha 1-Antitrypsin Deficiency7
Bronchitis, Chronic5
Respiratory Tract Diseases5
Lung Diseases, Obstructive4
Pathologic Processes3
Genetic Diseases, Inborn2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.